These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 29290793)

  • 1. Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas.
    Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
    Theranostics; 2018; 8(1):61-77. PubMed ID: 29290793
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic silencing of the 3p22 tumor suppressor DLEC1 by promoter CpG methylation in non-Hodgkin and Hodgkin lymphomas.
    Wang Z; Li L; Su X; Gao Z; Srivastava G; Murray PG; Ambinder R; Tao Q
    J Transl Med; 2012 Oct; 10():209. PubMed ID: 23050586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
    Zhang L; Zhang Q; Li L; Wang Z; Ying J; Fan Y; He Q; Lv T; Han W; Li J; Yang Y; Xu B; Wang L; Liu Q; Sun Y; Guo Y; Tao Q; Jin J
    J Mol Med (Berl); 2015 Jun; 93(6):691-701. PubMed ID: 25648635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
    Chan SL; Cui Y; van Hasselt A; Li H; Srivastava G; Jin H; Ng KM; Wang Y; Lee KY; Tsao GS; Zhong S; Robertson KD; Rha SY; Chan AT; Tao Q
    Lab Invest; 2007 Jul; 87(7):644-50. PubMed ID: 17384664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers.
    Ying J; Poon FF; Yu J; Geng H; Wong AH; Qiu GH; Goh HK; Rha SY; Tian L; Chan AT; Sung JJ; Tao Q
    Br J Cancer; 2009 Feb; 100(4):663-9. PubMed ID: 19156137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WNT5A antagonizes WNT/β-catenin signaling and is frequently silenced by promoter CpG methylation in esophageal squamous cell carcinoma.
    Li J; Ying J; Fan Y; Wu L; Ying Y; Chan AT; Srivastava G; Tao Q
    Cancer Biol Ther; 2010 Sep; 10(6):617-24. PubMed ID: 20603606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
    He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
    Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y; Fan J; Fan Y; Li L; He X; Xiang Q; Mu J; Zhou D; Sun X; Yang Y; Ren G; Tao Q; Xiang T
    Clin Epigenetics; 2018 Feb; 10(1):26. PubMed ID: 30359298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant promoter methylation of DLEC1, a critical 3p22 tumor suppressor for renal cell carcinoma, is associated with more advanced tumor stage.
    Zhang Q; Ying J; Li J; Fan Y; Poon FF; Ng KM; Tao Q; Jin J
    J Urol; 2010 Aug; 184(2):731-7. PubMed ID: 20639048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas.
    Li L; Ying J; Li H; Zhang Y; Shu X; Fan Y; Tan J; Cao Y; Tsao SW; Srivastava G; Chan AT; Tao Q
    Oncogene; 2012 Aug; 31(34):3901-12. PubMed ID: 22139084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
    Hibino S; Kanda M; Oya H; Takami H; Shimizu D; Nomoto S; Hishida M; Niwa Y; Koike M; Yamada S; Nishikawa Y; Asai M; Nakayama G; Fujii T; Sugimoto H; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Feb; 31(2):693-700. PubMed ID: 24317529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor gene DLEC1 is frequently silenced by DNA methylation in hepatocellular carcinoma and induces G1 arrest in cell cycle.
    Qiu GH; Salto-Tellez M; Ross JA; Yeo W; Cui Y; Wheelhouse N; Chen GG; Harrison D; Lai P; Tao Q; Hooi SC
    J Hepatol; 2008 Mar; 48(3):433-41. PubMed ID: 18191269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic deregulations of Wnt/β-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.
    Singh V; Singh AP; Sharma I; Singh LC; Sharma J; Borthakar BB; Rai AK; Kataki AC; Kapur S; Saxena S
    J Cancer Res Ther; 2019; 15(1):192-203. PubMed ID: 30880778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate tumor-suppressor gene DLEC1 is frequently downregulated by promoter hypermethylation and histone hypoacetylation in human epithelial ovarian cancer.
    Kwong J; Lee JY; Wong KK; Zhou X; Wong DT; Lo KW; Welch WR; Berkowitz RS; Mok SC
    Neoplasia; 2006 Apr; 8(4):268-78. PubMed ID: 16756719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma.
    Yamashita K; Kim MS; Park HL; Tokumaru Y; Osada M; Inoue H; Mori M; Sidransky D
    Mol Cancer Res; 2008 Jan; 6(1):31-41. PubMed ID: 18234960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
    Zhang W; Yan W; Qian N; Han Q; Zhang W; Dai G
    Chin Med J (Engl); 2022 Feb; 135(5):606-618. PubMed ID: 35191417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
    Mathews LA; Hurt EM; Zhang X; Farrar WL
    Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.